These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8077502)

  • 1. Pathogenesis of Candida infections.
    Odds FC
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S2-5. PubMed ID: 8077502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo.
    Schaller M; Januschke E; Schackert C; Woerle B; Korting HC
    J Med Microbiol; 2001 Aug; 50(8):743-747. PubMed ID: 11478679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.
    Naglik JR; Challacombe SJ; Hube B
    Microbiol Mol Biol Rev; 2003 Sep; 67(3):400-28, table of contents. PubMed ID: 12966142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Virulence factors of Candida albicans].
    Staniszewska M; Bondaryk M; Piłat J; Siennicka K; Magda U; Kurzatkowski W
    Przegl Epidemiol; 2012; 66(4):629-33. PubMed ID: 23484392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection.
    Kvaal C; Lachke SA; Srikantha T; Daniels K; McCoy J; Soll DR
    Infect Immun; 1999 Dec; 67(12):6652-62. PubMed ID: 10569787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Candida albicans secreted aspartic proteinase in the development of candidoses.
    Hoegl L; Ollert M; Korting HC
    J Mol Med (Berl); 1996 Mar; 74(3):135-42. PubMed ID: 8846163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy.
    Malic S; Hill KE; Ralphs JR; Hayes A; Thomas DW; Potts AJ; Williams DW
    Oral Microbiol Immunol; 2007 Jun; 22(3):188-94. PubMed ID: 17488445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyphal invasion of Candida albicans inhibits the expression of human beta-defensins in experimental oral candidiasis.
    Lu Q; Jayatilake JA; Samaranayake LP; Jin L
    J Invest Dermatol; 2006 Sep; 126(9):2049-56. PubMed ID: 16741514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis.
    Schaller M; Korting HC; Borelli C; Hamm G; Hube B
    Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartyl proteinases of Candida albicans and their role in pathogenicity.
    De Bernardis F; Sullivan PA; Cassone A
    Med Mycol; 2001 Aug; 39(4):303-13. PubMed ID: 11556759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
    Lian CH; Liu WD
    Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.
    Fotedar R; Al-Hedaithy SS
    Mycoses; 2005 Jan; 48(1):62-7. PubMed ID: 15679669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection.
    Taylor BN; Staib P; Binder A; Biesemeier A; Sehnal M; Röllinghoff M; Morschhäuser J; Schröppel K
    Infect Immun; 2005 Mar; 73(3):1828-35. PubMed ID: 15731084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections.
    Monika S; Małgorzata B; Zbigniew O
    Curr Protein Pept Sci; 2017; 18(10):1050-1062. PubMed ID: 27514853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis and morphogenesis of candidiasis].
    Bykov VL
    Arkh Patol; 1984; 46(12):75-82. PubMed ID: 6395838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients.
    Kumar CP; Kumar SS; Menon T
    Mycopathologia; 2006 Apr; 161(4):213-8. PubMed ID: 16552483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-parasite relationships in candidosis.
    Calderone RA
    Mycoses; 1989; 32 Suppl 2():12-7. PubMed ID: 2700215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis.
    Schaller M; Mailhammer R; Korting HC
    J Med Microbiol; 2002 Aug; 51(8):672-676. PubMed ID: 12171298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathomechanisms in Candida albicans infections].
    Ollert M; Korting HC; Braun-Falco O
    Hautarzt; 1988 Aug; 39(8):498-503. PubMed ID: 3065293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Aggregation Properties of Candida albicans Secreted Aspartyl Proteinase Sap6 Mediate Virulence in Oral Candidiasis.
    Kumar R; Saraswat D; Tati S; Edgerton M
    Infect Immun; 2015 Jul; 83(7):2614-26. PubMed ID: 25870228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.